Walking Intervention for Post-Amputation Care
(DASH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special walking program improves mobility in individuals who have lost a lower leg due to poor blood flow. Participants will receive biobehavioral training, which combines regular physical therapy with behavior and lifestyle sessions, primarily conducted through telehealth. The trial seeks individuals who have undergone a lower-leg amputation in the past year due to Type II Diabetes or Peripheral Artery Disease and wish to enhance their walking ability with a prosthetic. As a Phase 2 trial, it measures the treatment's effectiveness in an initial, smaller group, providing participants an opportunity to contribute to important research.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that participants generally find the walking program easy to handle. Studies on similar programs for individuals recovering from nontraumatic amputations have not identified any major problems, suggesting this approach is safe.
As this trial is in an early stage, much remains to be learned about the treatment's safety. However, past research is encouraging, as it has not revealed any significant safety issues. Participants in earlier studies responded well to the treatment, which is promising for those considering joining this trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the Walking Biobehavioral Intervention for post-amputation care because it integrates biobehavioral training with conventional outpatient rehabilitation, providing a holistic approach to recovery. Unlike standard care, which usually focuses solely on physical rehabilitation, this intervention incorporates psychological and behavioral support through ten sessions, including telehealth, over five months. This unique combination aims to improve patients' mobility and mental well-being, potentially leading to a more comprehensive recovery process.
What evidence suggests that the Walking Biobehavioral Intervention is effective for improving physical activity after lower limb amputation?
Research has shown that the Walking Biobehavioral Intervention, which participants in this trial may receive, can help individuals with lower limb amputations due to blood flow issues walk more. Studies have found that this intervention increases walking ability and reduces inactive time. For older veterans with nontraumatic amputations, this method effectively changed physical activity habits. Additionally, lifestyle interventions like this have improved physical fitness, walking skills, and overall quality of life for those with amputations. These findings suggest that the intervention could increase physical activity after an amputation.13467
Who Is on the Research Team?
Cory Christiansen, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for adults aged 50-85 who've had a lower-limb amputation within the last year due to diabetes or peripheral artery disease. They should aim to walk using a prosthesis and not be undergoing active cancer treatment, have had trauma or cancer-related limb loss, recent stroke, cognitive challenges, or any condition making it unsafe to participate as judged by the study leader.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Conventional Prosthetic Rehabilitation
Participants undergo conventional prosthetic rehabilitation as part of the intervention
Biobehavioral Intervention
Participants receive biobehavioral training integrated into conventional outpatient training
Follow-up
Participants are monitored for maintenance of physical activity and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- Walking Biobehavioral Intervention
Walking Biobehavioral Intervention is already approved in United Kingdom for the following indications:
- Improving physical activity after dysvascular lower limb amputation
- Managing intermittent claudication in peripheral artery disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator